tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Kalpit Patel, 71 are a BUY (82.56%), 15 are a HOLD (17.44%).
Analyst Kalpit Patel, currently employed at WOLFE, carries an average stock price target met ratio of 37.52% that have a potential upside of 32.13% achieved within 121 days. Previously, Kalpit Patel worked at CREDIT SUISSE, 2924.0, B. RILEY.
Kalpit Patel’s has documented 154 price targets and ratings displayed on 24 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on KYMR, Kymera Therapeutics at 29-Jun-2026.
Analyst best performing recommendations are on BCYC (BICYCLE THERAPEUTICS LTD).
The best stock recommendation documented was for VRDN (VIRIDIAN THERAPEUTICS) at 9/11/2024. The price target of $22 was fulfilled within 2 days with a profit of $2.2 (11.11%) receiving and performance score of 55.56.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 15-Feb-2022
$12
$7.9 (192.68%)
5 months 6 days ago
(08-Apr-2026)
0/8 (0%)
$7.02 (140.96%)
Buy Since 12-Jun-2020
$36
$31.9 (778.05%)
5 months 27 days ago
(18-Mar-2026)
3/11 (27.27%)
$31.3 (665.96%)
192
Buy Since 02-Mar-2022
$15
$10.9 (265.85%)
$29
5 months 27 days ago
(18-Mar-2026)
0/23 (0%)
$10.3 (219.15%)
Hold Since 18-Mar-2026
$7
$2.9 (70.73%)
5 months 27 days ago
(18-Mar-2026)
0/3 (0%)
$2.3 (48.94%)
Hold Since 24-Nov-2025
$10
$5.9 (143.90%)
$25
9 months 21 days ago
(24-Nov-2025)
0/5 (0%)
$3.26 (48.37%)
Which stock is Kalpit Patel most bullish on?
Which stock is Kalpit Patel most reserved on?
What Year was the first public recommendation made by Kalpit Patel?
